Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia
oleh: Howard A. Liebman, Mansoor N. Saleh, James B. Bussel, O. George Negrea, Heather Horne, William A. Wegener, David M. Goldenberg
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2016-11-01 |
Deskripsi
We compared two dosing schedules for subcutaneous injections of a low-dose humanized anti-CD20 antibody, veltuzumab, in immune thrombocytopenia. Fifty adults with primary immune thrombocytopenia, in whom one or more lines of standard therapy had failed and who had a platelet count